SPL UNCLASSIFIED SECTION
THE THREE-STEP SOLUTION
THE THREE-STEP SOLUTION
This serum is specially formulated to visibly reduce the appearance of dark spots.
Caution: Do not apply the serum on entire face. Use of the PhytoWhite™ Serum may make your skin more sensitive to the sun. Apply G.M. Collin sun protection before sun exposure while using this product and for a week afterwards.
PhytoWhite™ Cream: This treating cream hydrates, nourishes, and brightens skin. The complexion becomes clearer and uniform.
Mineral Sun Veil Cream SPF 15: Formulated exclusively with Zinc Oxide, it offers a complete protection against sunburn and skin damage caused by both UVA and UVB exposure.
Caution: Keep out of reach of children. For external use only. Discontinue use if signs of irritation appear. Can be used alone and on children 6 months and older. Avoid contact with eyes.
Use: After the G.M. Collin cleanser and treating lotion, apply the serum on dark spots only. Apply the cream on the entire face and complete with Sun Protection SPF 15 +.
Frequency: Morning and evening or as recommended by your skincare professional.
Ref. GV1652
PHYTOWHITE™ DARK SPOT SERUM
Ref. GV1642
WATER/EAU, SD ALCOHOL 3-A, BUTYLENE GLYCOL, GLYCOLIC ACID, ARGININE, POTASSIUM AZELOYL DIGLYCINATE, GLYCERIN, BRASSICA NAPUS EXTRACT, NIACINAMIDE, 1-METHYLHYDANTOINE-2-IMIDE, POLYSORBATE 20, ETHOXYDIGLYCOL, PHYLLANTHUS EMBLICA FRUIT EXTRACT, ERGOTHIONEINE, TETRAHYDRODIFERULOYLMETHANE, LICORICE EXTRACT, POTASSIUM ASCORBYL TOCOPHERYL PHOSPHATE (VITAMIN C, VITAMIN E), ALLANTOIN, HYDROXYPROPYLCELLULOSE, TETRAHYDROPIPERINE, PEG-40 HYDROGENATED CASTOR OIL, DISODIUM EDTA, SODIUM METABISULFITE, FRAGRANCE/PARFUM
PHYTOWHITE™ CREAM
Ref. GV1651
WATER/EAU, OLIGOPEPTIDE-34, ARACHIDYL ALCOHOL, BEHENYL ALCOHOL, ARACHIDYL GLUCOSIDE, NIACINAMIDE, BRASSICA NAPUS EXTRACT, PENTYLENE GLYCOL, GLYCERIN, DICAPRYLYL CARBONATE, SODIUM PCA, UREA, TREHALOSE, POLYQUATERNIUM-51, SODIUM HYALURONATE, LEPIDIUM SATIVUM SPROUT EXTRACT, PHENOXYETHANOL, LECITHIN, SOY ISOFLAVONES, POLYSORBATE 80 , ALCOHOL, SQUALANE (VEGETAL), PEG-8, CETEARYL ISONONANOATE, ASCORBYL GLUCOSIDE, PICHIA/RESVERATROL FERMENT EXTRACT, TOCOPHERYL ACETATE (VITAMIN E), ISOSTEARYL AVOCADATE, BUTYROSPERMUM PARKII (SHEA BUTTER), BIOSACCHARIDE GUM-1, DIPALMITOYL HYDROXYPROLINE, DIMETHICONE, SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, ISOHEXADECANE,CYCLOPENTASILOXAN E, CYCLOTETRASILOXANE, DIMETHICONOL, PEG-100 STEARATE, GLYCERYL STEARATE, ERGOTHIONEINE, ASCORBYL TETRA 2-HEXYLDECANOATE, XYLITYLGLUCOSIDE, ANHYDROXYLITOL, XYLITOL, CAPRYLIC/CAPRIC TRIGLYCERIDE, SOYBEAN (GLYCINE SOYA), PANTHENOL, C12-15 ALKYL BENZOATE, TRIBEHENIN, CERAMIDE 2, PEG-10 RAPESEED STEROL, PALMITOYL OLIGOPEPTIDE, FRAGRANCE/PARFUM, CHLORPHENESIN, ETHYLHEXYLGLYCERIN, SODIUM METABISULFITE, DISODIUM EDTA, SODIUM HYDROXIDE, SODIUM CITRATE, TETRADIBUTYL PENTAERITHRITYL HYDROXYHYDROCINNAMATE, XANTHAN GUM, CITRIC ACID
15 SPF MINERAL SUN VEIL CREAM
NDC 64127-014-02
Ref. GV1725
ZINC OXIDE 12.5%
CYCLOPENTASILOXANE, CYCLOHEXASILOXANE, PEG-10 DIMETHICONE, POLYSILICONE-11, WATER/EAU, DIMETHICONE/DIVINYLDIMETHICONE/SILSESQUIOXANE CROSSPOLYMER, COPERNICIA CERIFERA (CARNAUBA) WAX, PPG-15 STEARYL ETHER, CETYL PEG/PPG-10/1 DIMETHICONE, GLYCERIN, BUTYLENE GLYCOL, CITRUS MEDICA LIMONIUM (LEMON) EXTRACT, FUMARIA OFFICINALIS EXTRACT, FUMARIC ACID, SODIUM BENZOTRIAZOLYL BUTYLPHENOL SULFONATE, BUTETH-3, TRIBUTYL CITRATE, TRIS (TETRAMETHYLHYDROXYPIPERIDINOL) CITRATE, ETHYLHEXYLGLYCERIN, CHLORPHENESIN, CASSIA ALATA (CANDLE TREE) LEAF EXTRACT, TOCOPHEROL (VITAMIN E)
MADE IN CANADA
® LABORATOIRES DERMO-COSMETIK INC.
68 STINSON, MONTREAL, QUEBEC, CANADA H4N 2E7
SYSTÈME ÉCLAIRCISSANT
PHYTOWHITE™
BRIGHTENING SYSTEM
Tous types de peau
All Skin Types
NDC 64127-084-01
SÉRUM
ANTI-TACHES
PHYTOWHITE™
DARK SPOT
SERUM
20 ml – 0.68 fl. oz.
CRÈME
PHYTOWHITE™
CREAM
50 ml – 1.7 fl. oz.
VOILE SOLAIRE
MINERAL
SUN VEIL
FPS 15 SPF
50 ml – Net wt. 1.7 oz.

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64127-084-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c132-621f-e053-dbdaa90a74ad | PHYTOWHITE™ BRIGHTENING SYSTEM |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64127-084-01 | G.M. Collin Mineral Sun Veil | 1 in 1 KIT | CREAM | 1 | 1 | |
| 64127-084-01 | G.M. Collin Mineral Sun Veil | 50 mL in 1 TUBE | CREAM | 50 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| zinc oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| ALPHA-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| FUMARIC ACID | INACTIVE INGREDIENT | 88XHZ13131 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| LEMON | INACTIVE INGREDIENT | 24RS0A988O | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 64127-084 | 64127-084-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| zinc oxide | SOI2LOH54Z | ACTIB |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| CYCLOMETHICONE 6 | XHK3U310BA | IACT |
| WATER | 059QF0KO0R | IACT |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| LEMON | 24RS0A988O | IACT |
| FUMARIC ACID | 88XHZ13131 | IACT |
| ETHYLHEXYLGLYCERIN | 147D247K3P | IACT |
| CHLORPHENESIN | I670DAL4SZ | IACT |
| ALPHA-TOCOPHEROL | H4N855PNZ1 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| FUMARIC ACID | FUMARIC ACID | 88XHZ13131 | TABLET, CHEWABLE / ORAL | 120 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, DELAYED RELEASE / ORAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| FUMARIC ACID | FUMARIC ACID | 88XHZ13131 | TABLET, EXTENDED RELEASE / ORAL | 84 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 140 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| FUMARIC ACID | FUMARIC ACID | 88XHZ13131 | SUSPENSION / ORAL | 120 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | CAPSULE / ORAL | NA | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| FUMARIC ACID | FUMARIC ACID | 88XHZ13131 | SYRUP / ORAL | 0.75 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 567ff01c-685e-4eca-9617-3c188967d28b | 2619719a-c6e8-44e6-b396-c1bf5f8de38a | 2010-05-12 | 567ff01c-685e-4eca-9617-3c188967d28b 2619719a-c6e8-44e6-b396-c1bf5f8de38a |
Adverse event summaries are temporarily unavailable. Other product information remains available.